Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 6/20 | 0.52 |
| ▸ | CA1 | P00915 | 5/20 | 0.52 |
| ▸ | CA2 | P00918 | 5/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA4 | P22748 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | HTR6 | P50406 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | F2 | P00734 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29516284 | 1.00 | GAA (0.54) | GAACA9CA1CA2CA12 | |
| SCHEMBL3283108 | 0.87 | CA1 (0.47) | GAACA9CA1CA2CA12 | |
| SCHEMBL1458540 | 0.83 | CA1 (0.43) | GAACA9CA1CA2CA12 | |
| SCHEMBL8989782 | 0.82 | CA1 (0.46) | GAACA9CA1CA2LMNA | |
| SCHEMBL19834321 | 0.80 | GAA (0.54) | GAACA9CA1CA2CA12 | |
| SCHEMBL7576202 | 0.79 | GAA (0.62) | GAACA9CA1CA2CA12 | |
| SCHEMBL7180736 | 0.78 | CA1 (0.48) | CA9CA1CA2CYP2C9LMNA | |
| SCHEMBL7055443 | 0.77 | GAA (0.60) | GAACA9CA1CA2CA12 | |
| SCHEMBL19280567 | 0.76 | KMT2A (0.67) | CA9CA1CA2CYP2C9HTR6 | |
| SCHEMBL6913682 | 0.76 | CA1 (0.47) | CA9CA1CA2CYP2C9LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108080236-B | Method for improving corrosion resistance of desulfurization dust remover shell | 蚌埠青果科技服务有限公司 | 2021-12-21 | — | — | CN | claimed |
| US-10066152-B2 | Crosslinkable proppant particulates for use in subterranean formation operations | HALLIBURTON ENERGY SERVICES, INC. (US) | 2018-09-04 | — | — | US | claimed |
| US-20170198208-A1 | Crosslinkable Proppant Particulates For Use In Subterranean Formation Operations | HALLIBURTON ENERGY SERVICES, INC. (US) | 2017-07-13 | — | — | US | claimed |
| WO-2016025002-A1 | CROSSLINKABLE PROPPANT PARTICULATES FOR USE IN SUBTERRANEAN FORMATION OPERATIONS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-02-18 | — | — | WO | claimed |
| US-7635662-B2 | Compound for color-producing composition, and recording material | CHEMIPRO KASEI KAISHA, LTD. (JP) | 2009-12-22 | — | — | US | claimed |
| CN-118695780-A | Composition and method for producing the same | 阿斯制药株式会社 | 2024-09-24 | — | — | CN | disclosed |
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | ACENET INC. (JP) | 2024-01-04 | — | — | US | disclosed |
| CN-117281115-A | Free radical generating catalyst, method for producing free radical, method for producing oxidation reaction product, pharmaceutical agent, and agricultural and livestock pharmaceutical agent | 株式会社ACENET | 2023-12-26 | — | — | CN | disclosed |
| WO-2023190598-A1 | COMPOSITION | アース製薬株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-20230263710-A1 | ORAL CARE AGENT | OSAKA UNIVERSITY (JP) | 2023-08-24 | — | — | US | disclosed |
| EP-4230042-A1 | ANTIPATHOGENIC DRUG, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN PROCESSING DEVICE, METHOD FOR PRODUCING ANTIPATHOGENIC DRUG, ANTIBACTERIAL METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN PROCESSING METHOD | Acenet Inc. (JP) | 2023-08-23 | — | — | EP | disclosed |
| CN-116322332-A | Antipathogenic agent, antibacterial agent, antiviral agent, pathogen treatment device, method for producing antipathogenic agent, antibacterial method, virus inactivation method, and pathogen treatment method | 株式会社ACENET | 2023-06-23 | — | — | CN | disclosed |
| US-4994563-A | Dyeing, printing cellulose, silk, wool, synthetic polyamides; colorfastness | CIBA-GEIGY CORPORATION (US) | 1991-02-19 | — | — | US | disclosed |
| US-4965237-A | AROMATICITY-POSESSING ISOCYANATE COMPOUND, IMINO COMPOUND, AND ANILINE DERIVATIVE | MITSUBISHI PAPER MILLS, LTD. (JP) | 1990-10-23 | — | — | US | disclosed |
| EP-0349486-A2 | Azo dyes, their preparation and their use | CIBA-GEIGY AG (CH) | 1990-01-03 | — | — | EP | disclosed |
| EP-0032625-A2 | Water-soluble monoazo dyes | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-07-29 | — | — | EP | disclosed |
| EP-0023601-A1 | Process for dyeing and printing textile material containing cellulose | BASF Aktiengesellschaft (DE) | 1981-02-11 | — | — | EP | disclosed |
| US-4158670-A | QUATERNARY AMMONIUM OR PHOSPHONIUM PHASE TRANSFER AGENTS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1979-06-19 | — | — | US | disclosed |
| US-4080322-A | WATER SOLUBLE DYES FOR LEATHER, PAPER, AND NON-WOVEN TEXTILES | SANDOZ LTD. (CH) | 1978-03-21 | — | — | US | disclosed |
| US-4013631-A | SYNTHETIC FIBERS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263710-A1 | ORAL CARE AGENT | TAS2R39, TAS2R40, TAS2R45 | GAA 1316/4885CA9 135/4885CA1 2268/4885 |
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | EIF2AK2, HAO2, ZC3HAV1 | GAA 390/4885CA9 1674/4885CA1 3911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.